Shingrix

UNIISPL

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerGlaxoSmithKline Biologicals SA

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
5816084952
10 SYRINGE in 1 CARTON (58160-849-52) / .5 mL in 1 SYRINGE (58160-849-43)

Annotations

UNII (FDA Substance ID)

COB9FF6I46

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "COB9FF6I46",
    "rxcui": null,
    "inchikey": null,
    "display_name": "RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAMUSCULAR",
  "spl_meta": {
    "c46e8702-5680-462b-a093-0c7720f77020": {
      "match": "brand_token",
      "title": "SHINGRIX (ZOSTER VACCINE RECOMBINANT, ADJUVANTED) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS]",
      "spl_version": "1",
      "published_date": "2026-03-09"
    }
  },
  "productid": "58160-849_e8a2f0fb-062a-4adc-ac30-f378fbcf87ed",
  "productndc": "58160-849",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "product_type": "VACCINE",
  "substance_name": "RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN",
  "proprietary_name": "Shingrix",
  "active_ingred_unit": "ug/.5mL",
  "application_number": "BLA125614",
  "marketing_category": "BLA",
  "nonproprietary_name": "Zoster Vaccine Recombinant, Adjuvanted",
  "start_marketing_date": "20250716",
  "active_numerator_strength": "50"
}

Access this data programmatically

Query Shingrix and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs